Showing results (201-210 of 384) with videos related to

Sort By:
Pageof 39
Psychopathology|January 1, 1991
True conversive hallucinationsB Spivak, E Livnat, A Weizman, et al.
Climacteric : the Journal of the International Menopause Society|March 17, 2007
Depressed mood through women's reproductive cycle: correlation to mood at menopauseD Becker, A Orr, A Weizman, et al.
The Journal of Clinical Psychiatry|September 1, 1991
Paranoid schizophrenia in adolescenceA Apter, B Spivak, A Weizman, et al.
The Israel Medical Association Journal : IMAJ|May 11, 2000
Induction of mRNA for tumor necrosis factor-alpha and interleukin-1 beta in mice brain, spleen and liver in an animal model of Shigella-related seizuresY Nofech-Mozes, Y Yuhas, E Kaminsky, et al.
Brain Research|January 1, 1990
Effect of prenatal and neonatal chronic exposure to phenobarbital on central and peripheral benzodiazepine receptorsF Fares, A Weizman, C G Pick, et al.
Neuroendocrinology|June 1, 1993
Long-term testosterone or diethylstilbestrol treatment affects gamma-aminobutyric acid and central-type benzodiazepine receptors but not peripheral-type benzodiazepine receptors in the female rat brainS Bar-Ami, Z Amiri, A Weizman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 1999
Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? I. Alternation learning in obsessive-compulsive disorder: male-female comparisonsJ Zohar, H Hermesh, A Weizman, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 5, 2002
Association between severity of schizophrenic symptoms and urinary retentionR Shiloh, A Weizman, P Dorfman-Etrog, et al.
Nephron|January 1, 1980
Hyperprolactinemia: a possible cause of sexual impotence in male patients undergoing chronic hemodialysisV Gura, A Weizman, B Maoz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 7, 2000
The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label studyP Dorfman-Etrog, H Hermesh, L Prilipko, et al.
Pageof 39